venous access device


Also found in: Dictionary, Thesaurus, Legal, Acronyms, Encyclopedia.

venous access device

a catheter designed for continuous access to the venous system. Such devices may be required for long-term parenteral feeding or the administration of IV fluids or medications for a period of several days.
Enlarge picture
VENOUS ACCESS DEVICES: A. An over-the-needle catheter; B. An inside-the-needle catheter.
Enlarge picture
VENOUS ACCESS DEVICES: A. An over-the-needle catheter; B. An inside-the-needle catheter.

venous access device

A specially designed catheter for gaining and maintaining access to the venous system. This device provides access for patients who require intravenous fluids or medications for several days or more, e.g., those having a bone marrow transplant or who are receiving long-term total parenteral nutrition. See: venous port
See: illustration
See also: device
References in periodicals archive ?
Catheter fracture : a0 rare complication of totally implantable subclavian venous access devices.
Currently, Cathflo Activase is the only FDA-approved agent indicated for use in venous access devices obstructed by thrombus.
Catheter occlusion is the most common noninfectious complication seen with long-term central venous access devices.
Central venous access devices are being used more frequently as many critical medical therapies require their use.
This independent study offering is designed for nurses and other health care professionals who care for and educate adult patients regarding central venous access devices.
markets for venous access devices including peripherally inserted central catheters (PICCs), central venous catheters (CVCs), dialysis catheters, implantable ports, and catheter securement devices.
A recently published article on the care and maintenance of central venous access devices describes the benefits of intraluminal protection connectors for preventing catheter-related bloodstream infections (CR-BSI).
In a separate paper, Janice Gabriel, MPhil, PgD, BSc (Hons), RN writes about the British experience with StatLock for securement of intermediate to long-term venous access devices.
The Genentech Lytic Portfolio of clot-busting agents includes Activase(R) (alteplase, recombinant) tissue plasminogen activator (t-PA) for acute ischemic stroke, TNKase(R) (tenecteplase) for acute myocardial infarction, and Cathflo Activase(R) (alteplase, recombinant) for restoration of function to central venous access devices occluded by blood clots.